Myriad Genetics grants Chief Legal Officer Jennifer Lynne Fox 39,370 restricted stock units
MYGN•Myriad Genetics granted Chief Legal and Corporate Strategy Officer Jennifer Lynne Fox 39,370 common shares on Nov. 1, 2026.
1. Equity grant
Myriad Genetics granted Chief Legal and Corporate Strategy Officer Jennifer Lynne Fox 39,370 common shares on Nov. 1, 2026.
